semaglutide fda submission A big win for Wegovy: Weight loss drug first in history to gain approval for reducing heart risks FDA Clears Semaglutide For Cardiac

I'm so sick

A 2024 triple-blind RCT of 229 adults in JAMA Network Open found no significant difference in complete spontaneous bowel movements per week between HN019 and placebo over 8 weeks at 4.69 billion CFU per day

Review your complete medication list with your healthcare provider to identify any other drugs that may contribute to xerostomia, as dose adjustments or alternative medications may be possible in some cases

Tirzepatide products have their own refrigeration requirements that differ from semaglutide

This first-mover position gives Novo Nordisk a meaningful advantage in oral GLP-1 weight management, with potential to reshape real-world obesity care

The opportunity is the 12-month build between the recommendation and the rule